ARCA biopharma, Inc(NASDAQ:ABIO) 
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase 2 clinical trial for the treatme...
Website: http://arcabio.com
Founded: 2004
Full Time Employees: 13
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-03-05
P
O 1.67
H 1.68
L 1.62
C 1.67
V 47,759
10EMA 1.67
20EMA 1.67
60EMA 1.67
120EMA 1.67
250EMA 1.67